Ligands et complexes amphiphiles perfluoroalkylés à finalité biomédicale = Perfluoroalkylated amphiphilic ligands and complexes for biomedical usesGuillon, Christophe; Postel, M.1994, 98 p.Thesis

Synthesis and evaluation of potent and selective human V1a receptor antagonists as potential ligands for PET or SPECT imagingFABIO, Karine; GUILLON, Christophe; LACEY, Carl J et al.Bioorganic & medicinal chemistry. 2012, Vol 20, Num 3, pp 1337-1345, issn 0968-0896, 9 p.Article

Formulation of HIV-1 Tat and p24 antigens by PLA nanoparticles or MF59 impacts the breadth, but not the magnitude, of serum and faecal antibody responses in rabbitsGUILLON, Christophe; MAYOL, Katia; TERRAT, Céline et al.Vaccine. 2007, Vol 25, Num 43, pp 7491-7501, issn 0264-410X, 11 p.Article

Peripheral site acetylcholinesterase inhibitors targeting both inflammation and cholinergic dysfunctionYOUNG, Sherri; FABIO, Karine; GUILLON, Christophe et al.Bioorganic & medicinal chemistry letters (Print). 2010, Vol 20, Num 9, pp 2987-2990, issn 0960-894X, 4 p.Article

Design and characterization of an HIV-1 Tat mutant : Inactivation of viral and cellular functions but not antigenicityMAYOL, Katia; MUNIER, Séverine; BECK, Alain et al.Vaccine. 2007, Vol 25, Num 32, pp 6047-6060, issn 0264-410X, 14 p.Article

Calibration and alignment of the demonstrator of the PROBA-3/ASPIICS formation flying coronagraphCRESCENZIO, Giuseppe; CAPOBIANCO, Gerardo; DA DEPPO, Vania et al.Proceedings of SPIE, the International Society for Optical Engineering. 2010, Vol 7731, issn 0277-786X, isbn 978-0-8194-8221-1, 773148.1-773148.11, 3Conference Paper

Adaptive changes after human immunodeficiency virus type 1 transmissionLAWSON, Victoria A; OELRICHS, Robert; GUILLON, Christophe et al.AIDS research and human retroviruses. 2002, Vol 18, Num 8, pp 545-556, issn 0889-2229Article

Construction and characterisation of infectious recombinant HIV-1 clones containing CTL epitopes from structural proteins in NefGUILLON, Christophe; VAN BAALEN, Carel A; BOERS, Patrick H. M et al.Journal of virological methods. 2002, Vol 99, Num 1-2, pp 115-121, issn 0166-0934Article

Orally active vasopressin V1a receptor antagonist, SRX251, selectively blocks aggressive behaviorFERRIS, Craig F; LU, Shi-Fang; MESSENGER, Tara et al.Pharmacology, biochemistry and behavior. 2006, Vol 83, Num 2, pp 169-174, issn 0091-3057, 6 p.Article

Azetidinones as vasopressin V1a antagonistsGUILLON, Christophe D; KOPPEL, Gary A; COOPER, Robin D. G et al.Bioorganic & medicinal chemistry. 2007, Vol 15, Num 5, pp 2054-2080, issn 0968-0896, 27 p.Article